(Q33591606)

28 July 2017

1 reference

title

Nutritional support in hepatic encephalopathy (English)

1 reference

28 July 2017

Mizock BA

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

220-228

1 reference

Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Lung-liver interactions in sepsis and multiple organ failure syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

The neurobiology of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

The role of astrocytes in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

gamma-Aminobutyric acid plasma levels and brain binding in Eck fistula dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Brain metabolism in encephalopathy caused by hyperammonemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Cerebrospinal Fluid Glutamine as a Measure of Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Alpha-ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Selective loss of N-methyl-D-aspartate-sensitive L-[3H]glutamate binding sites in rat brain following portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

False neurotransmitters and hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Tryptophan transport across the blood-brain barrier during acute hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Ammonia selectively stimulates neutral amino acid transport across blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Changes in brain metabolism in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

CNS tryptamine metabolism in hepatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Glucose and insulin metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Is hepatic glycogen content a regulator of glucagon secretion?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Insulin-like growth factor-I in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Mechanism of insulin resistance associated with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Exogenous lipid clearance in compensated liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Branched chains revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Nutrition and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Protein-calorie malnutrition in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Accelerated improvement of alcoholic liver disease with enteral nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: meta analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Influences of exogenous intake and nitrogen balance on plasma and brain aromatic amino acid concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Role of Nutrition in Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Delayed gastric emptying in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effect of vegetable and animal protein diets in chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Nutrition support in clinical practice: review of published data and recommendations for future research directions. National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Nitrogen retention in critically ill patients is proportional to the branched chain amino acid load

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Role of parenteral nutrition in inflammatory bowel disease, acute renal failure, and hepatic encephalopathy. Clinical Efficacy Assessment Subcommittee of the Health and Public Policy Subcommittee, American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

ESPEN guidelines for nutrition in liver disease and transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Diminished bacterial defences with intralipid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Indications and effects of preoperative parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Nutritional monitoring in the ICU: rational and practical application.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Amino Acid Imbalance and Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

High lipid parenteral nutrition improves portasystemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Medium chain triglycerides and hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Management of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Trace metals in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Vitamins and Liver Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Overt hepatic encephalopathy precipitated by zinc deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Selenium in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

Successful treatment of hepatic coma probably caused by acute infectious hepatitis with balanced solution of amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900191-9

7 January 2021

10.1016/S0899-9007(98)00191-9

Identifiers

DOI

1 reference

28 July 2017

1 reference